BRENT KELTON

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Enveric Biosciences, Inc.

Filing Date Source Excerpt
2018-08-22 Consists of 93,176 shares of common stock.
2021-04-13 Brent Kelton (4) Former Chief Executive Officer resigned December 30, 2020.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22